Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

• Autores principales: Xavier Sáez-Llorens (Autor), Johnny Beltran-Rodriguez (Autor), Jose M. Novoa Pizarro (Autor), Ilhem Mensi (Autor), Pavitra Keshavan (Autor), Daniela Toneatto (Autor)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2018-05-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

This open-label, multicenter extension study (NCT02451514) assessed persistence of Neisseria meningitidis serogroups ABCWY antibodies 4 years after primary vaccination. Adolescents and young adults who previously received 2 doses of MenABCWY+OMV (Group III), 1 dose of MenACWY-CRM (Group VI), or newl...